Potassium channels — Drug Target
All drugs that target Potassium channels — marketed and clinical-stage. Includes 4 drug classes acting on this target.
Drug classes
Antiarrhythmic · Anti-arrhythmic · Potassium channel blocker · Class I anti-arrhythmic
Marketed (4)
- (C) D-V14 · National Taiwan University Hospital · Antiarrhythmic · Cardiovascular
D-V14 is a medication used to treat atrial fibrillation. - PL 1 · Technical University of Munich · Antiarrhythmic · Cardiovascular
PL 1 is a medication used to treat atrial fibrillation. - Changchun marina · Nanjing NingQi Medicine Science and Technology Co., Ltd. · Anti-arrhythmic · Cardiovascular
Changchun marina is a medication used to treat atrial fibrillation. - (B) T-V7 · National Taiwan University Hospital · Antiarrhythmic · Cardiovascular
T-V7 is a medication used to treat atrial fibrillation.
Phase 3 pipeline (3)
- TETA 4HCL (60-<W108) · Orphalan · Potassium channel blocker · Cardiovascular
TETA 4HCL is a tetraethylammonium chloride, a potassium channel blocker. - TETA 4HCL (W12-60) · Orphalan · Potassium channel blocker · Cardiovascular
TETA 4HCL (W12-60) is a tetraethylammonium chloride, a potassium channel blocker. - TETA 4HCl formulation · Orphalan · Potassium channel blocker · Cardiovascular
TETA 4HCl formulation is a tetraethylammonium chloride, a potassium channel blocker.
Phase 1 pipeline (1)
- Anti-Arrhythmic therapy · Imperial College London · Class I anti-arrhythmic · Cardiovascular
Blocks potassium channels to prevent arrhythmias